Literature DB >> 28652469

Blood Pressure and Visit-to-Visit Blood Pressure Variability Among Individuals With Primary Proteinuric Glomerulopathies.

Christine B Sethna1, Kevin E C Meyers2, Laura H Mariani2, Kevin J Psoter2, Crystal A Gadegbeku2, Keisha L Gibson2, Tarak Srivastava2, Matthias Kretzler2, Tammy M Brady2.   

Abstract

Hypertension and blood pressure variability (BPV; SD and average real variability) in primary proteinuric glomerulopathies are not well described. Data were from 433 participants in the NEPTUNE (Nephrotic Syndrome Study Network). Hypertensive BP status was defined as previous history of hypertension or BP ≥140/90 mm Hg for adults/≥95th percentile for children at baseline. BPV was measured in participants with ≥3 visits in the first year. Two-hundred ninety-six adults (43 years [interquartile range, 32-57.8 years], 61.5% male) and 147 children (11 years [interquartile range, 5-14 years], 57.8% male) were evaluated. At baseline, 64.8% of adults and 46.9% of children were hypertensive. Histological diagnosis was associated with hypertensive status in adults (P=0.036). In adults, hypertensive status was associated with lower hazard of complete remission (hazard ratio, 0.36; 95% confidence interval, 0.19-0.68) and greater hazard of achieving the composite end point (end-stage renal disease or estimated glomerular filtration rate decline >40%; hazard ratio, 4.1; 95% confidence interval, 1.4-12). Greater systolic and diastolic SD and average real variability were also associated with greater hazard of reaching the composite end point in adults (all P<0.01). In children, greater BPV was an independent predictor of composite end point (determined by systolic SD and average real variability) and complete remission (determined by systolic and diastolic average real variability; all P<0.05). Hypertensive status was common among adults and children enrolled in NEPTUNE. Differences in hypertensive status prevalence, BPV, and treatment were found by age and histological diagnosis. In addition, hypertensive status and greater BPV were associated with poorer clinical outcomes.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  adult; blood pressure; hypertension; nephrotic syndrome; prevalence

Mesh:

Year:  2017        PMID: 28652469      PMCID: PMC5518633          DOI: 10.1161/HYPERTENSIONAHA.117.09475

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Association of home blood pressure variability with progression of chronic kidney disease.

Authors:  Tomonari Okada; Hiroshi Matsumoto; Yume Nagaoka; Toshiyuki Nakao
Journal:  Blood Press Monit       Date:  2012-02       Impact factor: 1.444

3.  Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.

Authors:  Jeff Whittle; Amy I Lynch; Rikki M Tanner; Lara M Simpson; Barry R Davis; Mahboob Rahman; Paul K Whelton; Suzanne Oparil; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

Review 4.  Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension.

Authors:  Evan C Ray; Helbert Rondon-Berrios; Cary R Boyd; Thomas R Kleyman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

5.  Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.

Authors:  Francesca Mallamaci; Roberto Minutolo; Daniela Leonardis; Graziella D'Arrigo; Giovanni Tripepi; Francesco Rapisarda; Teresa Cicchetti; Igina Maimone; Giuseppe Enia; Maurizio Postorino; Domenico Santoro; Giorgio Fuiano; Luca De Nicola; Giuseppe Conte; Carmine Zoccali
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

6.  Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Morgan E Grams; Wei Yang; Casey M Rebholz; Xue Wang; Anna C Porter; Lesley A Inker; Edward Horwitz; James H Sondheimer; L Lee Hamm; Jiang He; Matthew R Weir; Bernard G Jaar; Tariq Shafi; Lawrence J Appel; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2017-03-30       Impact factor: 8.860

7.  [Relationship of 24-hour ambulatory blood pressure and rennin-angiotensin-aldosterone system in children with primary nephrotic syndrome].

Authors:  Zhi-Quan Xu; Zhu-Wen Yi; Xi-Qiang Dang; Xiao-Chuan Wu; Xiao-Jie He
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2010-10

8.  Relationships between metrics of visit-to-visit variability of blood pressure.

Authors:  E B Levitan; N Kaciroti; S Oparil; S Julius; P Muntner
Journal:  J Hum Hypertens       Date:  2013-03-28       Impact factor: 3.012

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease.

Authors:  Alberto Zagury; Anne Louise de Oliveira; Jose Augusto Araujo Montalvão; Regina Helena Leite Novaes; Vinicius Martins de Sá; Carlos Augusto Pinheiro de Moraes; Marcelo de Sousa Tavares
Journal:  J Bras Nefrol       Date:  2013 Jul-Sep
View more
  9 in total

1.  Visit-to-visit blood pressure variability in children and adolescents with renal disease.

Authors:  Hisayo Fujita; Seiji Matsuoka; Midori Awazu
Journal:  Clin Exp Nephrol       Date:  2018-03-14       Impact factor: 2.801

2.  Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study.

Authors:  Christine B Sethna; Derek K Ng; Shuai Jiang; Jeff Saland; Bradley A Warady; Susan Furth; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2019-03-22       Impact factor: 3.714

3.  Executive functioning, caregiver monitoring, and medication adherence over time in adolescents with chronic kidney disease.

Authors:  Cyd K Eaton; Kara M Duraccio; Michelle N Eakin; Tammy M Brady; Cozumel S Pruette; Thomas Eckmann; Susan R Mendley; Shamir Tuchman; Barbara A Fivush; Kristin A Riekert
Journal:  Health Psychol       Date:  2020-03-23       Impact factor: 4.267

4.  Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.

Authors:  Amanda P Waller; Jonathan P Troost; Samir V Parikh; Katelyn J Wolfgang; Brad H Rovin; Marvin T Nieman; William E Smoyer; Matthias Kretzler; Bryce A Kerlin
Journal:  Thromb Res       Date:  2021-02-16       Impact factor: 3.944

5.  Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.

Authors:  Isa F Ashoor; Sarah A Mansfield; Michelle M O'Shaughnessy; Rulan S Parekh; Jarcy Zee; Tetyana L Vasylyeva; Amy J Kogon; Christine B Sethna; Dorey A Glenn; Aftab S Chishti; Donald J Weaver; Margaret E Helmuth; Hilda E Fernandez; Michelle N Rheault
Journal:  J Am Heart Assoc       Date:  2019-07-09       Impact factor: 5.501

6.  Clinicopathologic characteristics, pathology, and prognosis of 77 dogs with focal segmental glomerulosclerosis.

Authors:  Sarah K Lorbach; Jessica A Hokamp; Jessica M Quimby; Rachel E Cianciolo
Journal:  J Vet Intern Med       Date:  2020-07-07       Impact factor: 3.333

7.  Short-term blood pressure variability and outcomes in non-dialysis chronic kidney disease.

Authors:  Ge Wang; Kai Ma; Zhilan Ma; Xiaoyan Guo; Yan Wang; Lan Ma; Chenchen Qi; Yan Li; Xiaoling Zhou
Journal:  Front Med (Lausanne)       Date:  2022-09-27

8.  Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies.

Authors:  Paras P Shah; Tammy M Brady; Kevin E C Meyers; Michelle M O'Shaughnessy; Keisha L Gibson; Tarak Srivastava; Jarcy Zee; Daniel Cattran; Katherine R Tuttle; Crystal Gadegbeku; Dorey Glenn; Vimal Derebail; Abigail Smith; Chia-Shi Wang; Brenda W Gillespie; Markus Bitzer; Christine B Sethna
Journal:  Nephron       Date:  2021-03-05       Impact factor: 2.847

9.  Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, -a common cause of nephrotic syndrome.

Authors:  Gaofei Yan; Guanzhi Liu; Xuefei Tian; Lifang Tian; Hao Wang; Peiyao Ren; Xiaotao Ma; Rongguo Fu; Zhao Chen
Journal:  BMC Nephrol       Date:  2020-09-14       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.